News
A subcutaneous injection is an injection into the fatty tissue. There are many types, and people use them to treat diabetes and other conditions. Learn more about subcutaneous injections ...
Subcutaneous injection of COYA 302, an anti-inflammatory, Treg-enhancing combination biologic (comprising low dose interleukin-2 and CTLA-4 Ig fusion protein), in an inflammatory mouse model of PD ...
Injection site reactions to etanercept usually occur within the first month of treatment. They most commonly occur 1 to 2 days after an injection, and the duration is usually 3 to 5 days.
Immunotherapy for renal cell carcinoma (RCC) can be given as a subcutaneous injection or IV infusion. Here is what to consider.
Their insulin was able to regulate blood-glucose levels for a week in diabetic mice and minipigs after a single subcutaneous injection. “Theoretically, [smart insulin is] ...
CHICAGO — An oral robotic pill may provide an alternative delivery method to subcutaneous injection for teriparatide and other biologics, according to a speaker at ENDO 2023. In findings from a ...
The phase 3 OCARINA 2 study has been evaluating the subcutaneous formulation compared with the IV in 236 patients with relapsing or primary progressive MS. The Ocrevus subcutaneous injection was shown ...
The FDA approved atezolizumab and hyaluronidase-tqjs for subcutaneous injection.The agent (Tecentriq Hybreza, Genentech) is the first subcutaneous anti-PD-L1 cancer immunotherapy approved in the ...
FDA accepts Braeburn’s New Drug Application resubmission for Brixadi ™ (buprenorphine) extended-release subcutaneous injection for moderate to severe opioid use disorder. News release. Braeburn.
Roche’s subcutaneous version of its multiple sclerosis (MS) med Ocrevus triumphed in a key late-stage study, likely setting up a new opportunity for the blockbuster drug.. The study, called ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results